| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1900 | 2020 |
| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1426 | 2019 |
| Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study MA Slavin, B Osborne, R Adams, MJ Levenstein, HG Schoch, ... Journal of Infectious Diseases 171 (6), 1545, 1995 | 966 | 1995 |
| The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports W Jeong, C Keighley, R Wolfe, WL Lee, MA Slavin, DCM Kong, ... Clinical microbiology and infection 25 (1), 26-34, 2019 | 939 | 2019 |
| Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of … KA Marr, K Seidel, MA Slavin, RA Bowden, HG Schoch, MED Flowers, ... Blood, The Journal of the American Society of Hematology 96 (6), 2055-2061, 2000 | 626 | 2000 |
| Combination antifungal therapy for invasive aspergillosis: a randomized trial KA Marr, HT Schlamm, R Herbrecht, ST Rottinghaus, EJ Bow, OA Cornely, ... Annals of internal medicine 162 (2), 81-89, 2015 | 517 | 2015 |
| Echinocandin antifungal drugs in fungal infections: a comparison SCA Chen, MA Slavin, TC Sorrell Drugs 71, 11-41, 2011 | 463 | 2011 |
| Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients P Troke, K Aguirrebengoa, C Arteaga, D Ellis, CH Heath, I Lutsar, ... Antimicrobial agents and chemotherapy 52 (5), 1743-1750, 2008 | 307 | 2008 |
| European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia JA Maertens, C Girmenia, RJ Brüggemann, RF Duarte, CC Kibbler, ... Journal of Antimicrobial Chemotherapy 73 (12), 3221-3230, 2018 | 286 | 2018 |
| Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised … CO Morrissey, SCA Chen, TC Sorrell, S Milliken, PG Bardy, KF Bradstock, ... The Lancet Infectious Diseases 13 (6), 519-528, 2013 | 242 | 2013 |
| Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. MA Slavin, JD Meyers, JS Remington, RC Hackman Bone marrow transplantation 13 (5), 549-557, 1994 | 239 | 1994 |
| Active surveillance for candidemia, Australia S Chen, M Slavin, Q Nguyen, D Marriott, EG Playford, D Ellis, T Sorrell Emerging infectious diseases 12 (10), 1508, 2006 | 236 | 2006 |
| Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients CC Blyth, SCA Chen, MA Slavin, C Serena, Q Nguyen, D Marriott, D Ellis, ... Pediatrics 123 (5), 1360-1368, 2009 | 221 | 2009 |
| Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and Terbinafine BP Howden, MA Slavin, AP Schwarer, AM Mijch European Journal of Clinical Microbiology and Infectious Diseases 22, 111-113, 2003 | 220 | 2003 |
| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 218 | 2021 |
| Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab KA Thursky, LJ Worth, JF Seymour, H Miles Prince, MA Slavin British journal of haematology 132 (1), 3-12, 2006 | 215 | 2006 |
| Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp EG Playford, D Marriott, Q Nguyen, S Chen, D Ellis, M Slavin, TC Sorrell Critical care medicine 36 (7), 2034, 2008 | 213 | 2008 |
| Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death SCA Chen, MA Slavin, CH Heath, EG Playford, K Byth, D Marriott, SE Kidd, ... Clinical infectious diseases 55 (6), 789-798, 2012 | 204 | 2012 |
| Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing PL White, JR Wingard, S Bretagne, J Löffler, TF Patterson, MA Slavin, ... Clinical Infectious Diseases 61 (8), 1293-1303, 2015 | 194 | 2015 |
| Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality M Slavin, S Van Hal, TC Sorrell, A Lee, DJ Marriott, K Daveson, ... Clinical Microbiology and Infection 21 (5), 490. e1-490. e10, 2015 | 191 | 2015 |
Professor Karin ThurskyRoyal Melbourne Hospital, Peter MacCallum Cancer Centre, University of Melbourne確認したメール アドレス: mh.org.au
